Articles related to CARDIOGENIC SHOCK

In a recent randomized, multicenter trial, the use of a microaxial flow pump in addition to standard care resulted in a mortality reduction at 180 days among STEMI patients with cardiogenic shock, with a significant hazard ratio of 0.74.

In this detailed case study, physicians will gain insights into the layered complexity of managing post-infarction complications, emphasizing the critical interplay between timely surgical intervention and vigilant post-operative monitoring in preserving patient outcomes.

The recent multicenter trial on ECLS in cardiogenic shock complicating acute myocardial infarction raises questions about its efficacy and safety.